This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Walgreens Boots' (WBA) Q3 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) U.S. Healthcare business expands, owing to key contract wins, continued partnership growth and a strong focus on execution.
Durables, Case-Shiller and Walgreens Mark a Busy Morning
by Mark Vickery
While Durable Goods Orders rose unexpectedly, Case-Shiller home prices fell for the second straight month, and Walgreens Boots Alliance missed on the bottom line.
Here's What Key Metrics Tell Us About Walgreens (WBA) Q3 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Walgreens (WBA) give a sense of how the business performed in the quarter ended May 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Walgreens Boots Alliance (WBA) Q3 Earnings Miss Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -5.66% and 4.82%, respectively, for the quarter ended May 2023. Do the numbers hold clues to what lies ahead for the stock?
Markets Flat-to-Down to Start a New Trading Week
by Mark Vickery
There were zero major economic reports out this morning, with only Carnival (CCL) posting quarterly earnings.
Walgreens (WBA) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Continued strategic executions on the United States and the international front is likely to drive Walgreens' (WBA) Q3 revenues.
Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DJD
Zacks Market Edge Highlights: CTAS, GWW, CAT, WBA and IBM
by Zacks Equity Research
CTAS, GWW, CAT, WBA and IBM have been highlighted in this Market Edge article.
Want Passive Income? Try Investing in Stocks
by Tracey Ryniec
Why launch a YouTube channel when you can buy companies that have paid dividends for decades?
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $32.39, moving -0.86% from the previous trading session.
Why You Should Retain Walgreens Boots (WBA) Stock for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots (WBA) on a strong focus on strategic priorities.
Walgreens Boots Alliance (WBA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots (WBA) Aids Freenome in Early Cancer Detection
by Zacks Equity Research
The collaboration between Walgreens Boots (WBA) and Freenome to advance research based on the early detection of cancer.
ETF Investing Strategies for 2H 2023
by Neena Mishra
We discuss the midyear ETF market outlook and investment ideas.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $31.95, marking a +0.98% move from the previous day.
Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SDY
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $31.93, moving +1.27% from the previous trading session.
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DJD
Walgreens (WBA) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Walgreens (WBA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Walgreens Boots (WBA) Gains From New Alliances Amid Macro Woes
by Zacks Equity Research
Continued slowdown in generic introduction has been affecting Walgreens Boots' (WBA) margins.
The Zacks Analyst Blog Highlights NVIDIA, Bristol-Myers Squibb, ICICI Bank, Palo Alto and Walgreens Boots Alliance
by Zacks Equity Research
NVIDIA, Bristol-Myers Squibb, ICICI Bank, Palo Alto and Walgreens Boots Alliance are included in this Analyst Blog.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $30.32, moving -0.16% from the previous trading session.
Top Analyst Reports for NVIDIA, Bristol-Myers Squibb & ICICI Bank
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Bristol-Myers Squibb Company (BMY) and ICICI Bank Limited (IBN).
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $30, marking a +0.1% move from the previous day.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $31.46 in the latest trading session, marking a -1.81% move from the prior day.